About 200 reports

Global Immunology Partnering 2014-2019: Deal trends, players and financials Chapter ## – Introduction Chapter ## – Trends in Immunology dealmaking ##. ##.

  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • Demand
  • IMMUNOLOGY MARKET IN EMEA
  • Market size: Global immunology market

You can easily book an appointment with one online.

  • Immunology
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • A) Global immunology market split
  • A) Global immunology market size

Only one JAK inhibitor, Xeljanz, is approved for the immunology market.

  • Immunology
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Business Overview Product Portfoilio Financials SWOT Analysis FUTURE OUTLOOK OF THE MARKET ABBREVIATIONS APPENDIX: PRESS RELEASES Chart List List of Charts: Europe Immunology Market Size, 2013 - 2023 (US$M) Europe Immunology Market Size, by Region, 2013 - 2023 (US$M) Europe

  • Health Services
  • Immunology
  • Therapy
  • Europe
  • Market Size

Business Overview Product Portfoilio Financials SWOT Analysis FUTURE OUTLOOK OF THE MARKET ABBREVIATIONS APPENDIX: PRESS RELEASES Chart List List of Charts: Brazil Immunology Market Size, 2013 - 2023 (US$M) Brazil Immunology Market Size, by Region, 2013 - 2023 (US$M) Brazil

  • Immunology
  • Brazil
  • BRIC
  • China
  • Market Size
  • 3.4.4 Immunology
  • D) Immunology

The drug claimed blockbuster status just one year after its launch.

  • Immunology
  • Pharmaceutical
  • Therapy
  • Company
  • Market Size
  • 4.2.4 Immunology
  • 3.4.4 Immunology

Health Affairs; ##(##): ##-## Vernon J, et al. (2010).

  • Clinical Trial
  • Immunology
  • Pharmaceutical
  • Therapy
  • Market Size
  • La Jolla Institute for Allergy & Immunology - Key Competitors
  • La Jolla Institute for Allergy & Immunology, Key Competitors

GlobalData La Jolla Institute for Allergy & Immunology reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Allergy
  • Chronic Disease
  • Immunology
  • United States
  • Deals & Alliance
  • IMMUNOLOGY DRUGS MARKET, 7MM, EPIDEMIOLOGY OF KEY IMMUNOLOGY INDICATIONS, 2018
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, PIPELINE FOR KEY IMMUNOLOGY INDICATIONS BY

Cellular Immunology; ##(##): ##-## Webster AC, et al. (2005).

  • Healthcare
  • Immunology
  • Monoclonal Antibody
  • Company Financials
  • Forecast
  • Institute for Research in Immunology and Cancer, Key Employees
  • Institute for Research in Immunology and Cancer - Key Competitors

GlobalData Therapy Area Central Nervous System Gastrointestinal Immunology Infectious Disease Metabolic Disorders Oncology No. of Deals ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA NA Institute for Research in Immunology and Cancer, Medical Devices

  • Healthcare
  • Immunology
  • Pharmaceutical
  • Therapy
  • Canada
  • PROPORTION OF CORNEAL GRAFT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*
  • PROPORTION OF CORNEAL GRAFT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*

The prominent features of this report are - ##.

  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF PEANUT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF PEANUT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*

Hoffmann-La Roche Ltd ## ## ## ## ## AnaptysBio Inc ## ## ## ## ## Food Allergy Research & Education Inc ## ## ## ## ## Novartis AG ## ## ## ## ## Droege International Group AG ## ## ## ## ## Allertein Therapeutics LLC ## ## ## ## ## Allergy Therapeutics Plc Source: Globa

  • Immunology
  • Medical Biotechnology
  • World
  • Product Initiative
  • Aimmune Therapeutics, Inc.
  • Immunology, Multiple Sclerosis, Non- Alcoholic Steatohepatitis
  • SMALL MOLECULES TO ANTAGONIZE ROR GAMMA FOR GASTROINTESTINAL AND IMMUNOLOGY DISORDERS - DRUG PROFILE

One patient has a confirmed partial response (cPR) and is ## of ## patients that remain on study.

  • Autoimmune Disease
  • Immunology
  • United States
  • World
  • Product Initiative
  • ANTISENSE OLIGONUCLEOTIDE TO ANTAGONIZE ROR GAMMA FOR IMMUNOLOGY - DRUG PROFILE
  • SMALL MOLECULES TO ANTAGONIZE ROR GAMMA FOR GASTROINTESTINAL AND IMMUNOLOGY DISORDERS - DRUG PROFILE

One patient has a confirmed partial response (cPR) and is ## of ## patients that remain on study.

  • Immunology
  • United States
  • World
  • Product Initiative
  • Lycera Corp.
  • 6.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, Q2 2019
  • Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$

One ADS right entitles an ADS holder to subscribe for and purchase one new ADS.

  • Dermatology
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • 4.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, 2017
  • Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2014 - 2018

AVXS-##, has highly compelling clinical data in treating SMA Type ##, which is the number one genetic cause of death in infants.

  • Endocrine Disease
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • PROPORTION OF CHURG-STRAUSS SYNDROME TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2019*
  • PROPORTION OF CHURG-STRAUSS SYNDROME TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS

The prominent features of this report are - ##.

  • Immunology
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Synergenics, LLC
  • PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2019*
  • PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF CUTANEOUS LUPUS ERYTHEMATOSUS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2019*
  • PROPORTION OF CUTANEOUS LUPUS ERYTHEMATOSUS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Immunotherapy
  • World
  • Product Initiative
  • PROPORTION OF CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS (CCLE) / DISCOID LUPUS ERYTHEMATOSUS (DLE) TO IMMUNOLOGY CLINICAL
  • PROPORTION OF CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS (CCLE) / DISCOID LUPUS ERYTHEMATOSUS (DLE) TO IMMUNOLOGY CLINICAL

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Immunotherapy
  • World
  • Product Initiative
  • Versatile Innovation in Immunology, Global,
  • Versatile Innovation in Immunology, Global,

Immunology; ##(##): ##-## Rachakonda T, et al. (2014).

  • Health Services
  • Healthcare
  • Immunology
  • Medical Biotechnology
  • Deals & Alliance
  • PROPORTION OF BIRCH POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2018*
  • PROPORTION OF BIRCH POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Allergy
  • Allergy Immunotherapy
  • Immunology
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CAT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF CAT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Circassia Pharmaceuticals plc
  • PROPORTION OF CORNEAL GRAFT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • PROPORTION OF CORNEAL GRAFT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*

## ## ## ## ## ## Lux Biosciences Inc ## ## ## ## ## ## Laboratoires CTRS ## ## ## ## ## ## Price Vision Group Oxford BioMedica Plc Mediante GmbH Advanced Biotherapy Inc (Inactive) Source: GlobalData' s Pharma Intelligence Center Clinical Trials Datab

  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF WISKOTT-ALDRICH SYNDROME TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF WISKOTT-ALDRICH SYNDROME TO IMMUNOLOGY CLINICAL TRIALS

The prominent features of this report are - ##.

  • Cell Therapy
  • Immunology
  • Medical Biotechnology
  • World
  • Product Initiative
  • 6.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, Q4 2018

(GDS), a US-based provider of transfusional diagnostics and immunology services.

  • Immunology
  • Neurology
  • World
  • Deals & Alliance
  • AstraZeneca PLC
  • PROPORTION OF SARCOIDOSIS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF SARCOIDOSIS TO IMMUNOLOGY CLINICAL TRIALS

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • Therapy
  • Celgene Corporation
  • PROPORTION OF ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS (ANCA VASCULITIS) TO IMMUNOLOGY CLINICAL TRIALS, E7
  • PROPORTION OF ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS (ANCA VASCULITIS) TO IMMUNOLOGY CLINICAL TRIALS, E7

The prominent features of this report are - ##.

  • Autoimmune Disease
  • Drug Development
  • Immunology
  • World
  • Product Initiative
  • PROPORTION OF STEM CELL TRANSPLANTATION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2018*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF STEM CELL TRANSPLANTATION TO IMMUNOLOGY CLINICAL TRIALS

The prominent features of this report are - ##.

  • Drug Development
  • General Medicine And Specialty Medicine
  • Immunology
  • World
  • Product Initiative